Yıl: 2023 Cilt: 29 Sayı: 3 Sayfa Aralığı: 428 - 436 Metin Dili: İngilizce DOI: 10.4274/dir.2022.221462 İndeks Tarihi: 07-06-2023

Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd–Chiari syndrome

Öz:
PURPOSE In Budd–Chiari syndrome (BCS), unevenly distributed parenchymal changes and perfusion abnormalities occur due to hepatic venous outflow obstruction. This study aimed to evaluate the changes in the liver parenchyma in BCS using the quantitative magnetic resonance (MR) techniques of MR elastography, T1 and T2 mapping, and diffusion imaging and correlate the quantitative MR parameters through biochemical results and prognostic indices. METHODS Fourteen patients with BCS (seven men and seven women) were examined retrospectively. Liver stiffness (kPa), T1 relaxation times (ms) were achieved using the modified Look–Locker inversion recovery (MOLLI) 3(2)3(2)5 sequence and B1-corrected variable flip angle methods, T2 relaxation times (ms), and apparent diffusion coefficient (ADC) values (mm2/s) were measured using regions of interest placed in the same region in all quantitative methods. Measurements were repeated at the precontrast and postcontrast hepatobiliary phases. The reduction rate (RR; %) and adjusted postcontrast T1 (%) were calculated. The values obtained from different liver parenchyma areas (whole liver, caudate lobe, pathological T2 hyperintense tissue, and relatively preserved normal-appearing tissue) were compared using the Wilcoxon signed-rank test. Spearman’s correlation coefficient was used to investigate the correlation between quantitative MR parameters and biochemical parameters/ prognostic scores (Child–Pugh score, Clichy score, and Rotterdam index). RESULTS The parenchymal stiffness and precontrast T1 values of the caudate lobe were significantly lower than those of the remainder of the parenchyma, whereas the adjusted postcontrast T1 percentages (MOLLI) were significantly higher (P ≤ 0.027). The parenchymal stiffness value, T1 and T2 values, percentages of RR (MOLLI), and adjusted postcontrast T1 values for the pathological tissue and relatively normal tissue were significantly different (P < 0.028). No significant difference was found in terms of ADC values between any of the distinct regions of the liver. A strong correlation was detected between the Child–Pugh score, Clichy score, and precontrast T1 values obtained through the MOLLI sequence (r = 0.867, P = 0.012, r = 0.821, P = 0.023, respectively). No correlation was found between the whole liver stiffness values and the laboratory parameters, fibrosis markers, prognostic indices, or MR parameters. A significant correlation was identified between creatinine levels and several T1 parameters and the T2 relaxation time (r ≥ 0.661, P ≤ 0.052). CONCLUSION Tissue stiffness and T1 relaxation values are high in the areas identified as fibrosis compared with those in the relatively preserved parenchyma. The T1 relaxation time can offer quantitative information for assessing segmental functional changes and prognosis in BCS.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Janssen HL, Garcia-Pagan JC, et al. Budd- Chiari syndrome: a review by an expert panel. J Hepatol. 2003;38(3):364-371. [CrossRef]
  • 2. Valla DC. The diagnosis and management of the Budd-Chiari syndrome: consensus and controversies. Hepatology. 2003;38(4):793- 803. [CrossRef]
  • 3. Plompen EPC, Darwish Murad S, Hansen BE, et al. Prothrombotic genetic risk factors are associated with an increased risk of liver fibrosis in the general population: the Rotterdam study. J Hepatol. 2015;63(6):1459- 1465. [CrossRef]
  • 4. Xu P, Lyu L, Sami MU, et al. Diagnostic accuracy of magnetic resonance angiography for Budd- Chiari syndrome: a meta-analysis. Exp Ther Med. 2018;16(6):4873-4878. [CrossRef]
  • 5. Li Q, Chen T, Shi N, Ye W, Yuan M, Shi Y. Quantitative evaluation of hepatic fibrosis by fibro Scan and Gd-EOB-DTPA-enhanced T1 mapping magnetic resonance imaging in chronic hepatitis B. Abdom Radiol (NY). 2022;47(2):684-692. [CrossRef]
  • 6. Simonetto DA, Yang HY, Yin M, et al. Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces. Hepatology. 2015;61(2):648-659. [CrossRef]
  • 7. Idilman IS, Li J, Yin M, Venkatesh SK. MR elastography of liver: current status and future perspectives. Abdom Radiol (NY). 2020;45(11):3444-3462. [CrossRef]
  • 8. Cazals-Hatem D, Vilgrain V, Genin P, et al. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers. Hepatology. 2003;37(3):510-519. [CrossRef]
  • 9. Sakr M, Abdelhakam SM, Elsayed SA, et al. Validation of prognostic indices in Egyptian Budd-Chiari syndrome patients: a single-center study. World J Gastroenterol. 2017;23(4):629-637. [CrossRef]
  • 10. Noone TC, Semelka RC, Siegelman ES, et al. Budd-Chiari syndrome: spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging. J Magn Reson Imaging. 2000;11(1):44- 50. [CrossRef]
  • 11. Katsube T, Okada M, Kumano S, et al. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol. 2011;46(4):277-283. Erratum in: Invest Radiol. 2013;48(2):112. [CrossRef]
  • 12. Yoon JH, Lee JM, Paek M, Han JK, Choi BI. Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOBDTPA- enhanced liver MR imaging. Eur Radiol. 2016;26(6):1775-1782. [CrossRef]
  • 13. Faria SC, Ganesan K, Mwangi I, et al. MR imaging of liver fibrosis: current state of the art. Radiographics. 2009;29(6):1615- 1635. [CrossRef]
  • 14. Ferraioli G, Barr R. Ultrasound liver elastography beyond liver fibrosis assessment. World J Gastroenterol. 2020;26(24):3413-3420. [CrossRef]
  • 15. Mukund A, Pargewar SS, Desai SN, Rajesh S, Sarin SK. Changes in liver congestion in patients with Budd-Chiari syndrome following endovascular ınterventions: assessment with transient elastography. J Vasc Interv Radiol. 2017;28(5):683-687. [CrossRef]
  • 16. Wang HW, Shi HN, Cheng J, Xie F, Luo YK, Tang J. Real-time shear wave elastography (SWE) assessment of short- and long-term treatment outcome in Budd-Chiari syndrome: a pilot study. PLoS One. 2018;13(5):e0197550. [CrossRef]
  • 17. Srinivasa Babu A, Wells ML, Teytelboym OM, et al. Elastography in chronic liver disease: modalities, techniques, limitations, and future directions. Radiographics. 2016;36(7):1987- 2006. [CrossRef]
  • 18. Xu P, Lyu L, Ge H, et al. Segmental liver stiffness evaluated with magnetic resonance elastography ıs responsive to endovascular ıntervention in patients with Budd-Chiari syndrome. Korean J Radiol. 2019;20(5):773- 780. [CrossRef]
  • 19. Xu P, Lyu L, Lu X, Hu C, Xu K. Evaluating the short-term clinical efficacy of magnetic resonance elastography in patients with Budd- Chiari syndrome. Acad Radiol. 2021;28(Suppl 1):S179-S183. [CrossRef]
  • 20. Mukund A, Sarin SK. Budd-Chiari syndrome: a focussed and collaborative approach. Hepatol Int. 2018;12(6):483-486. [CrossRef]
  • 21. Erden A, Erden I, Yurdaydin C, Karayalçin S. Hepatic outflow obstruction: enhancement patterns of the liver on MR angiography. Eur J Radiol. 2003;48(2):203-208. [CrossRef]
  • 22. Mancuso A. An update on management of Budd-Chiari syndrome: the issues of timing and choice of treatment. Eur J Gastroenterol Hepatol. 2015;27(3):200-203. [CrossRef]
  • 23. Coilly A, Potier P, Broué P, et al. Budd-Chiari syndrome. Clin Res Hepatol Gastroenterol. 2020;44(4):420-425. [CrossRef]
  • 24. Erden A, Erden I, Karayalçin S, Yurdaydin C. Budd-Chiari syndrome: evaluation with multiphase contrast-enhanced threedimensional MR angiography. AJR Am J Roentgenol. 2002;179(5):1287-1292. [CrossRef]
  • 25. Nilsson H, Blomqvist L, Douglas L, et al. Dynamic gadoxetate-enhanced MRI for the assessment of total and segmental liver function and volume in primary sclerosing cholangitis. J Magn Reson Imaging. 2014;39(4):879-886. [CrossRef]
  • 26. Kamimura K, Fukukura Y, Yoneyama T, et al. Quantitative evaluation of liver function with T1 relaxation time index on gadoxetic acid-enhanced MRI: comparison with signal intensity-based indices. J Magn Reson Imaging. 2014;40(4):884-889. [CrossRef]
  • 27. Haimerl M, Verloh N, Zeman F, et al. Assessment of clinical signs of liver cirrhosis using T1 mapping on gadoxetic acid-enhanced 3T MRI. PLoS One. 2013;8(12):e85658. [CrossRef]
  • 28. Qi X, Ren W, Wang Y, Guo X, Fan D. Survival and prognostic indicators in Budd-Chiari syndrome: a systematic review of 79 studies. Expert Rev Gastroenterol Hepatol. 2015;9(6):856-875. [CrossRef]
  • 29. Fortune B, Cardenas A. Ascites, refractory ascites and hyponatremia in cirrhosis. Gastroenterol Rep (Oxf). 2017;5(2):104- 112. [CrossRef]
  • 30. Zeitoun G, Escolano S, Hadengue A, et al. Outcome of Budd Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology. 1999;30(1):84-89. [CrossRef]
APA Erden A, Kuru Oz D, ADIGÜZEL M, OZALP ATES F (2023). Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd–Chiari syndrome. , 428 - 436. 10.4274/dir.2022.221462
Chicago Erden Ayşe,Kuru Oz Digdem,ADIGÜZEL MEHMET,OZALP ATES FUNDA SEHER Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd–Chiari syndrome. (2023): 428 - 436. 10.4274/dir.2022.221462
MLA Erden Ayşe,Kuru Oz Digdem,ADIGÜZEL MEHMET,OZALP ATES FUNDA SEHER Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd–Chiari syndrome. , 2023, ss.428 - 436. 10.4274/dir.2022.221462
AMA Erden A,Kuru Oz D,ADIGÜZEL M,OZALP ATES F Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd–Chiari syndrome. . 2023; 428 - 436. 10.4274/dir.2022.221462
Vancouver Erden A,Kuru Oz D,ADIGÜZEL M,OZALP ATES F Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd–Chiari syndrome. . 2023; 428 - 436. 10.4274/dir.2022.221462
IEEE Erden A,Kuru Oz D,ADIGÜZEL M,OZALP ATES F "Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd–Chiari syndrome." , ss.428 - 436, 2023. 10.4274/dir.2022.221462
ISNAD Erden, Ayşe vd. "Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd–Chiari syndrome". (2023), 428-436. https://doi.org/10.4274/dir.2022.221462
APA Erden A, Kuru Oz D, ADIGÜZEL M, OZALP ATES F (2023). Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd–Chiari syndrome. Diagnostic and Interventional Radiology, 29(3), 428 - 436. 10.4274/dir.2022.221462
Chicago Erden Ayşe,Kuru Oz Digdem,ADIGÜZEL MEHMET,OZALP ATES FUNDA SEHER Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd–Chiari syndrome. Diagnostic and Interventional Radiology 29, no.3 (2023): 428 - 436. 10.4274/dir.2022.221462
MLA Erden Ayşe,Kuru Oz Digdem,ADIGÜZEL MEHMET,OZALP ATES FUNDA SEHER Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd–Chiari syndrome. Diagnostic and Interventional Radiology, vol.29, no.3, 2023, ss.428 - 436. 10.4274/dir.2022.221462
AMA Erden A,Kuru Oz D,ADIGÜZEL M,OZALP ATES F Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd–Chiari syndrome. Diagnostic and Interventional Radiology. 2023; 29(3): 428 - 436. 10.4274/dir.2022.221462
Vancouver Erden A,Kuru Oz D,ADIGÜZEL M,OZALP ATES F Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd–Chiari syndrome. Diagnostic and Interventional Radiology. 2023; 29(3): 428 - 436. 10.4274/dir.2022.221462
IEEE Erden A,Kuru Oz D,ADIGÜZEL M,OZALP ATES F "Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd–Chiari syndrome." Diagnostic and Interventional Radiology, 29, ss.428 - 436, 2023. 10.4274/dir.2022.221462
ISNAD Erden, Ayşe vd. "Quantitative liver magnetic resonance imaging: correlation between conventional magnetic resonance imaging, laboratory values, and prognostic indices in Budd–Chiari syndrome". Diagnostic and Interventional Radiology 29/3 (2023), 428-436. https://doi.org/10.4274/dir.2022.221462